Clinical Comparison Study

Hema-T vs. C.A.T. Tourniquet

A head-to-head comparative study evaluating Hema-T against the Combat Application Tourniquet (C.A.T.) across efficacy, pain, and ease of use — conducted by the IDF Medical Corps, Trauma and Combat Medicine Branch.

Download Comparison PDF
Methodology

Study Design

Objective

To compare Hema-T (auto-transfusion tourniquet) with C.A.T. (Combat Application Tourniquet) for limb hemorrhage control in a combat-medicine context.

Participants

35 IDF combat medics — 30 men, 5 women, ages 18–21

Protocol

Random assignment: each participant applied both tourniquets on arm and leg

Evaluation Criteria

Doppler ultrasound verification of arterial occlusion, application time, pain score (VAS), and ease-of-use rating

Maj. Dr. RY • B.Sc. IR • Lt. Col. Dr. DHN • Lt. Col. Dr. AO — IDF Medical Corps, Trauma and Combat Medicine Branch

Findings

Key Results

Similar studies: USA 2022 — 62% occlusion success | Israel 2015 — 78% occlusion success

Arterial Occlusion
100%

Both Hema-T and C.A.T. achieved full arterial occlusion in 100% of applications, verified by Doppler ultrasound.

Pain Reduction
~60%

Hema-T produced approximately 60% lower pain scores than C.A.T. for both arm and leg applications (p<0.05).

Head to Head

Hema-T vs. C.A.T. — Head to Head

CriterionHema-TC.A.T.
Arterial Occlusion100%100%
Pain Score (VAS)~60% lowerBaseline
Auto-TransfusionYes — blood returned to circulationNo
Blood TrappingPreventedOccurs
Washout on ReleasePreventedOccurs
Application SpeedFastFast
Why Hema-T

Hema-T Advantages

Identical Efficacy

100% arterial occlusion success rate — equal to C.A.T., the current gold standard.

Significantly Less Pain

~60% reduction in pain scores during application (p<0.05), improving compliance and patient experience.

Auto-Transfusion

Unique dual function: controls hemorrhage while simultaneously returning blood to the central circulation.

No Blood Trapping

Prevents blood from being trapped in the limb, reducing the risk of complications upon tourniquet release.

No Washout Effect

Eliminates the washout of cold, acidic, hyperkalaemic blood into the central circulation on release.

Safe Duration

Safe for continuous use up to 120 minutes — suitable for prolonged field care scenarios.

Summary

Conclusion

Hema-T demonstrates identical hemorrhage-control efficacy to the C.A.T. while delivering significantly less pain and the added clinical benefit of auto-transfusion. It represents a superior option for combat and pre-hospital limb tourniquet application.